Shattuck Labs, Inc. Earnings Per Share (Basic)
Shattuck Labs, Inc. (STTK) reported Earnings Per Share (Basic) of -$0.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Shattuck Labs, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.12.
- Shattuck Labs, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.13.
- Shattuck Labs, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.12.
- Shattuck Labs, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.14.
- Shattuck Labs, Inc. earnings per share, basic for fiscal 2025 was -$0.70.
- Shattuck Labs, Inc. earnings per share, basic for fiscal 2024 was -$1.49.
- Shattuck Labs, Inc. earnings per share, basic for fiscal 2023 was -$2.05.
- Shattuck Labs, Inc. earnings per share, basic for fiscal 2022 was -$2.41.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.12 10-Q · filed 2026-08-11 | -$0.25 10-Q · filed 2026-08-11 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2026-03-31 | -$0.13 10-Q · filed 2026-05-07 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.70 10-K · filed 2026-03-05 |
| 2025-09-30 | -$0.14 10-Q · filed 2025-11-06 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.62 10-Q · filed 2025-11-06 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.24 10-Q · filed 2026-08-11 | -$0.51 10-Q · filed 2026-08-11 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.21 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.27 10-Q · filed 2026-05-07 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2024-12-31 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$1.49 10-K · filed 2026-03-05 |
| 2024-09-30 | -$0.33 10-Q · filed 2025-11-06 | -$0.75 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.12 10-Q · filed 2025-11-06 | -$1.52 derived: net income ÷ weighted average shares · filed 2025-11-06 |
| 2024-06-30 | -$0.42 10-Q · filed 2025-08-14 | -$0.79 10-Q · filed 2025-08-14 | -$1.20 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.83 derived: net income ÷ weighted average shares · filed 2025-11-06 |
| 2024-03-31 | -$0.37 10-Q · filed 2025-05-01 | -$0.77 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.41 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.91 derived: net income ÷ weighted average shares · filed 2025-11-06 |
| 2023-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.06 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.56 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$2.05 10-K · filed 2025-03-27 |
| 2023-09-30 | -$0.65 10-Q · filed 2024-11-14 | -$1.15 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$1.64 10-Q · filed 2024-11-14 | -$2.24 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-06-30 | -$0.50 10-Q · filed 2024-08-01 | -$0.99 10-Q · filed 2024-08-01 | -$1.59 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$2.17 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-03-31 | -$0.49 10-Q · filed 2024-05-02 | -$1.09 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$1.67 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$2.31 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2022-12-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.18 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.83 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$2.41 10-K · filed 2024-02-29 |
| 2022-09-30 | -$0.58 10-Q · filed 2023-11-09 | -$1.23 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.81 10-Q · filed 2023-11-09 | -$1.62 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.65 10-Q · filed 2023-08-10 | -$1.22 10-Q · filed 2023-08-10 | -$1.04 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.45 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.58 10-Q · filed 2023-05-09 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.81 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | $0.19 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$0.23 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$0.79 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$1.07 10-K · filed 2023-02-23 |
| 2021-09-30 | -$0.41 10-Q · filed 2022-11-09 | -$0.98 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.26 10-Q · filed 2022-11-09 | -$1.57 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-06-30 | -$0.56 10-Q · filed 2022-08-11 | -$0.85 10-Q · filed 2022-08-11 | -$1.16 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.82 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-03-31 | -$0.28 10-Q · filed 2022-05-12 | -$0.59 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.21 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.74 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2020-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$1.02 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$1.66 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$2.36 10-K · filed 2022-03-15 |
| 2020-09-30 | -$1.54 10-Q · filed 2021-11-09 | -$2.35 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$3.21 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$0.81 10-Q · filed 2021-08-12 | -$1.67 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |